Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Diabetes Update Refresher

The screening method should be simple

    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • RX
  • 4 minute read

To diagnose diabetes, there are several methods with certain advantages and disadvantages. Given that today one in two adults with diabetes remains undiagnosed, screening is strongly recommended for individuals 40 years of age and older. One criterion for the screening method in practice is ease of use. In one of his presentations at the Diabetes Update in Zurich, Prof. Roger Lehmann compared the different methods and showed which statements are possible with them. HbA1c is now also newly approved for diagnostics.

HbA1c refers to glycosylated hemoglobin. The proportion of HbA1c in total hemoglobin provides information about the average blood glucose level over the last twelve weeks. With an average lifetime of erythrocytes (and thus their hemoglobin) of about 100 days, the normal HbA1c value is less than 5.5% of total hemoglobin. “The measurement of HbA1c is extremely meaningful, not only for monitoring progress, but also for the diagnosis of diabetes,” said Prof. Roger Lehmann, senior physician at the Department of Endocrinology, Diabetology and Clinical Nutrition at the University Hospital Zurich and one of the keynote speakers at Diabetes Update. Also, the blood glucose criteria for diagnosis are simpler for HbA1c than for plasma glucose [1].

Advantages of HbA1c measurements

With the HbA1c the development of diabetes within five years can be predicted as follows: with an HbA1c of 5.5-6%, the chances are 9-25% that a diabetes diagnosis will be made, the HbA is1c 6.0-6.5%, the chances are 25-50%, i.e. they are 20 times higher than for a  HbA1c of 5.0% [2]. In one study, the relationship between the occurrence of retinopathy and the HbA1c value was investigated [3]: The result shows a significant increase from a value of 6.5%, where 6.5% corresponds to the threshold for the diagnosis of diabetes. This result further shows that the better the blood glucose control, the lower the risk of secondary diseases for diabetes patients.

Prof. Lehmann also explained how high the influence of the blood glucose control of the last three months on the HbA1c is: In the first month it is 50%, in the second month 25% and in the third and fourth month also 25%. “In this way, an improvement in blood glucose control can also be recorded after just one month, for example, in the event of a change in therapy.” Prof. Lehmann sees a major advantage of HbA1c in the improved mapping of chronic glycemia. Compared with fasting plasma glucose and OGGT, the other advantages are:

  • This is a standardized measurement method.
  • Biological variability (2%) is lower than fasting plasma glucose (12-15%).
  • Better correlation and predication of secondary complications.
  • It is preanalytically more stable and independent of time of day or stress.
  • It is the main parameter for therapy adjustment.

Certain limitations should be noted, however; HbA1c is not suitable for diagnosis in the following conditions:

  • Hemoglobinopathies (HbS, HbC, HbF, HbE),
  • increased erythrocyte turnover (hemolytic anemia, blood transfusion, subclinical hemolysis in HIV)
  • severe hepatic and renal insufficiency
  • Gestational diabetes or diabetes associated with cystic fibrosis
  • Interference with iron deficiency results in falsely high HbA1c, intake of high doses.
  • Vitamin C and E provides a falsely low value, in general HbA1c is about 0.4% higher in patients over 70 years old.

Conversion to be simplified

The conversion of HbA1c to average plasma glucose is not linear; moreover, there are two standards: DDCT, which is expressed as a percentage, and the newer IFCC, which is measured in mmol/mol. To obtain the average plasma glucose from HbA1c, calculate as follows: An HbA1c of 6% corresponds to a blood glucose of 7 mmol/l. Per percent HbA1c, add 1.6 mM [4]. This means that an HbA1c of 7.0% corresponds to an average blood glucose of 8.6 mM. Prof. Lehmann points out that in the future these conversions will be simplified to make them easier to understand for physicians and patients. Prof. Lehmann refers here to the scheme of the internationally standardized measurement method [5], see figure 1.

 

 

A comparison of tests for prognosis on the cumulative incidence of diabetes over five to six years shows that predictions using HbA1c are similar to those using fasting plasma glucose or the OGTT with 75 g glucose [6]. The Whitehall II study examined the progression of diabetes [7], in 6538 individuals without diabetes aged 35 to 55 years. In the process, 505 cases of diabetes were detected. Measurements of glucose and insulin yielded the following results: NPG increases two years before diabetes diagnosis, postprandial glucose six years before. For insulin secretion, the study showed that it increases four years before diagnosis and decreases two years before diagnosis, while insulin sensitivity decreases more five years before diagnosis.

Source: Forum for Continuing Medical Education, Diabetes Update Refresher, presentation “Diagnosis of Diabetes Mellitus,” November 24, 2016.

 

Literature:

  1. Diabetes Care 2011; 34: 11-61
  2. Diabetes Care 2009; 32, online June 5
  3. Diabetes Care 2010; 33: 1655-73
  4. Diabetes Care 2008; 31: 1473-78
  5. Kerner W: Definition, classification and diagnosis, Diabetology 2010; 5: 109-112.
  6. ADA Position Statement: Diabetes Care 2003, Suppl. 1, 26: 562-69
  7. Tobacco Inc, et al: Lancet 2009; 373: 2215-21.

 

HAUSARZT PRAXIS 2017; 12(1): 38-39

Autoren
  • Karin Diodà
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Blood sugar
  • Diabetes
  • Glucose
  • Sugar
Previous Article
  • Stroke Center and Stroke Unit

Supply in Switzerland

  • Education
  • Emergency and intensive care medicine
  • Neurology
  • RX
View Post
Next Article
  • Preoperative cardiac workup before non-cardiac surgery.

Fewer perioperative complications, better prognosis

  • Cardiology
  • Education
  • General Internal Medicine
  • RX
View Post
You May Also Like
View Post
  • 2 min
  • Chronic pain

Nano-ECS modulator Adezunap improves therapy success

    • Congress Reports
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Rheumatology
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis and PsA

Biologics, oral peptide and trivalent nanobody – current results and trends

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Cancer in Europe: facts and analysis

New Health Policy Report published

    • General Internal Medicine
    • Oncology
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • Gastrointestinal complaints

PPI regulation under the microscope

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Wound management: clinical diagnostics

Assessing the risk of infection – from the ABCDE to the TILI score

    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Infectiology
    • Interviews
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
View Post
  • 4 min
  • Study report

Digital patient education for atrial fibrillation shows measurable effects

    • Cardiology
    • Education
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 23 min
  • Important basics and studies on cancer and the psyche

Interplay between cancer and mental illness

    • CME continuing education
    • Oncology
    • Psychiatry and psychotherapy
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    How combination therapies lead to better treatment results
  • 2
    Interplay between cancer and mental illness
  • 3
    PH and lung diseases
  • 4
    Treatment of comorbidities in older people
  • 5
    Multidisciplinary teams in oncology

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.